(-)-cotinine multiple interactions ISO RGD:2327 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA CTD PMID:29617909 (R)-adrenaline decreases expression EXP 6480464 Epinephrine results in decreased expression of CEBPB protein CTD PMID:31520687 (S)-amphetamine increases expression EXP 6480464 Dextroamphetamine results in increased expression of CEBPB mRNA CTD PMID:12558987 (S)-nicotine increases expression ISO RGD:736208 6480464 Nicotine results in increased expression of CEBPB mRNA CTD PMID:18805435 (S)-nicotine multiple interactions ISO RGD:2327 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA CTD PMID:29617909 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of CEBPB mRNA CTD PMID:26682919 1,2,4-trimethylbenzene increases expression ISO RGD:2327 6480464 pseudocumene results in increased expression of CEBPB protein CTD PMID:17337753 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of CEBPB mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CEBPB mRNA CTD PMID:22206623 1-naphthyl isothiocyanate multiple interactions ISO RGD:736208 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CEBPB mRNA CTD PMID:27344345 1-nitropyrene increases expression ISO RGD:736208 6480464 1-nitropyrene results in increased expression of CEBPB mRNA CTD PMID:19428942 14-Deoxy-11,12-didehydroandrographolide multiple interactions EXP 6480464 14-deoxy-11 more ... CTD PMID:30248417 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CEBPB mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:2327 6480464 Ethinyl Estradiol results in increased expression of CEBPB mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPB mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of CEBPB mRNA CTD PMID:15289156 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of CEBPB mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:736208 6480464 Estradiol results in increased expression of CEBPB mRNA CTD PMID:23373633 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CEBPB mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:736208 6480464 CEBPB protein affects the reaction [Estradiol results in increased expression of KLRC3 mRNA], Estradiol promotes the reaction [ESR1 protein binds to CEBPB protein] CTD PMID:17395694 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:24559133 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPB mRNA CTD PMID:14505802 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2327 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPB mRNA CTD PMID:27913140 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736208 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPB mRNA CTD PMID:16263508 , PMID:17823287 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CEBPB mRNA CTD PMID:20702594 , PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2327 6480464 Tetrachlorodibenzodioxin affects the expression of CEBPB mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2327 6480464 Tetrachlorodibenzodioxin results in increased expression of CEBPB mRNA, Tetrachlorodibenzodioxin results in increased expression of CEBPB protein CTD PMID:19692669 , PMID:21777668 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2327 6480464 geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]] more ... CTD PMID:11133817 , PMID:21777668 2,3,7,8-tetrachlorodibenzodioxine increases activity EXP 6480464 Tetrachlorodibenzodioxin results in increased activity of CEBPB protein CTD PMID:14505802 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CEBPB mRNA, Tetrachlorodibenzodioxin results in decreased expression of CEBPB protein CTD PMID:12758056 , PMID:14708085 2,3,7,8-tetrachlorodibenzodioxine increases response to substance EXP 6480464 CEBPB protein results in increased susceptibility to Tetrachlorodibenzodioxin CTD PMID:11979424 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPB protein] more ... CTD PMID:12758056 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:736208 6480464 Tetrachlorodibenzodioxin results in increased activity of CEBPB protein CTD PMID:19147701 2,3,7,8-Tetrachlorodibenzofuran affects expression EXP 6480464 2 more ... CTD PMID:20702594 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA CTD PMID:18200517 2,4-dibromophenyl 2,4,5-tribromophenyl ether multiple interactions EXP 6480464 2 more ... CTD PMID:30903904 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:736208 6480464 2 more ... CTD PMID:26705709 2-acetamidofluorene decreases expression ISO RGD:2327 6480464 2-Acetylaminofluorene results in decreased expression of CEBPB protein CTD PMID:21785164 2-acetamidofluorene multiple interactions ISO RGD:2327 6480464 2-Acetylaminofluorene inhibits the reaction [CEBPB protein binds to HAMP promoter] CTD PMID:21785164 2-bromohexadecanoic acid multiple interactions ISO RGD:736208 6480464 2-bromopalmitate promotes the reaction [Tretinoin results in increased expression of CEBPB mRNA] CTD PMID:30076181 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of CEBPB mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:736208 6480464 beta-methylcholine affects the expression of CEBPB mRNA CTD PMID:21179406 3',5'-cyclic AMP increases response to substance EXP 6480464 CEBPB protein results in increased susceptibility to Cyclic AMP CTD PMID:23097472 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2327 6480464 3 more ... CTD PMID:19692669 3,4-methylenedioxymethamphetamine increases expression ISO RGD:2327 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of CEBPB mRNA CTD PMID:30071829 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:2327 6480464 1-Methyl-3-isobutylxanthine promotes the reaction [FSHB protein results in increased expression of CEBPB protein] CTD PMID:25253736 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736208 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA, [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA CTD PMID:28628672 , PMID:33836827 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 14-deoxy-11 more ... CTD PMID:16054899 more ... 3-methylcholanthrene multiple interactions EXP 6480464 [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA], [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] CTD PMID:21250977 3H-1,2-dithiole-3-thione decreases expression ISO RGD:2327 6480464 1, 2-dithiol-3-thione results in decreased expression of CEBPB mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CEBPB mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CEBPB mRNA CTD PMID:28973697 4-phenylbutyric acid multiple interactions ISO RGD:736208 6480464 4-phenylbutyric acid inhibits the reaction [honokiol results in decreased activity of CEBPB protein] CTD PMID:34973135 5-aza-2'-deoxycytidine affects expression ISO RGD:736208 6480464 Decitabine affects the expression of CEBPB mRNA CTD PMID:23300844 5-fluorouracil increases expression ISO RGD:736208 6480464 Fluorouracil results in increased expression of CEBPB mRNA CTD PMID:16557594 more ... 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide decreases expression ISO RGD:2327 6480464 6-chloro-2 more ... CTD PMID:29653943 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:2327 6480464 DDIT3 protein affects the reaction [6-chloro-2 more ... CTD PMID:29653943 6-propyl-2-thiouracil decreases expression ISO RGD:2327 6480464 Propylthiouracil results in decreased expression of CEBPB mRNA, Propylthiouracil results in decreased expression of CEBPB protein CTD PMID:26459835 8-(4-chlorophenylthio)-cGMP increases expression EXP 6480464 8-((4-chlorophenyl)thio)cyclic-3', 5'-GMP results in increased expression of CEBPB protein CTD PMID:20471953 8-(4-chlorophenylthio)-cGMP multiple interactions EXP 6480464 8-(4-chlorophenylthio)guanosine 3' more ... CTD PMID:20471953 9-cis-retinoic acid multiple interactions ISO RGD:2327 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased activity of CEBPB protein CTD PMID:15150131 acetaldehyde multiple interactions EXP 6480464 Acetaldehyde promotes the reaction [CEBPB protein binds to COL1A1 enhancer] CTD PMID:10613735 acetaldehyde increases expression EXP 6480464 Acetaldehyde results in increased expression of CEBPB protein CTD PMID:10613735 acetaldehyde multiple interactions ISO RGD:2327 6480464 [Acetaldehyde promotes the reaction [CEBPB protein binds to COL1A1 promoter]] which results in increased expression of COL1A1 mRNA, Acetaldehyde promotes the reaction [CEBPB protein binds to COL1A1 promoter] CTD PMID:10871045 acetylsalicylic acid multiple interactions ISO RGD:736208 6480464 Aspirin promotes the reaction [CEBPB protein binds to IL4 promoter polymorphism] CTD PMID:20921925 acrylamide multiple interactions EXP 6480464 Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein], Acrylamide promotes the reaction [Dietary Fats results in increased phosphorylation of CEBPB protein] CTD PMID:30409764 acrylamide increases expression ISO RGD:736208 6480464 Acrylamide results in increased expression of CEBPB mRNA CTD PMID:32763439 actinomycin D decreases expression ISO RGD:736208 6480464 Dactinomycin results in decreased expression of CEBPB mRNA CTD PMID:16001973 aflatoxin B1 increases expression ISO RGD:2327 6480464 Aflatoxin B1 results in increased expression of CEBPB mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO RGD:736208 6480464 Aflatoxin B1 results in decreased expression of CEBPB mRNA CTD PMID:32234424 AICA ribonucleotide increases phosphorylation ISO RGD:736208 6480464 AICA ribonucleotide results in increased phosphorylation of CEBPB protein CTD PMID:28038998 aldehydo-D-glucose multiple interactions ISO RGD:736208 6480464 CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CEBPB protein CTD PMID:29266779 aldehydo-D-glucose multiple interactions EXP 6480464 CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein] more ... CTD PMID:28482072 , PMID:29266779 all-trans-retinoic acid affects localization ISO RGD:736208 6480464 Tretinoin affects the localization of CEBPB protein CTD PMID:16608438 all-trans-retinoic acid increases expression ISO RGD:2327 6480464 Tretinoin results in increased expression of CEBPB mRNA, Tretinoin results in increased expression of CEBPB protein CTD PMID:14568882 , PMID:24977338 all-trans-retinoic acid increases expression ISO RGD:736208 6480464 Tretinoin results in increased expression of CEBPB mRNA more ... CTD PMID:15498508 more ... all-trans-retinoic acid increases activity ISO RGD:736208 6480464 Tretinoin results in increased activity of CEBPB protein alternative form CTD PMID:16608438 all-trans-retinoic acid multiple interactions ISO RGD:736208 6480464 2-bromopalmitate promotes the reaction [Tretinoin results in increased expression of CEBPB mRNA] more ... CTD PMID:15894607 more ... alpha-linolenic acid decreases expression ISO RGD:2327 6480464 alpha-Linolenic Acid results in decreased expression of CEBPB mRNA CTD PMID:14563831 amiodarone increases expression ISO RGD:736208 6480464 Amiodarone results in increased expression of CEBPB mRNA CTD PMID:19774075 amiodarone increases expression ISO RGD:2327 6480464 Amiodarone results in increased expression of CEBPB mRNA CTD PMID:25580480 ammonium chloride affects expression ISO RGD:2327 6480464 Ammonium Chloride affects the expression of CEBPB mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:2327 6480464 Amphetamine results in increased expression of CEBPB mRNA CTD PMID:30779732 andrographolide multiple interactions EXP 6480464 andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA], andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein] CTD PMID:27475717 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:736208 6480464 pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA] more ... CTD PMID:14729647 , PMID:24376792 antimycin A increases expression ISO RGD:736208 6480464 Antimycin A results in increased expression of CEBPB mRNA CTD PMID:33512557 apigenin decreases expression EXP 6480464 Apigenin results in decreased expression of CEBPB mRNA CTD PMID:18359623 aripiprazole multiple interactions ISO RGD:736208 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CEBPB mRNA CTD PMID:31476115 aristolochic acid A increases expression ISO RGD:736208 6480464 aristolochic acid I results in increased expression of CEBPB mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:736208 6480464 Arsenic results in decreased expression of CEBPB mRNA, Arsenic results in decreased expression of CEBPB protein CTD PMID:23108036 arsane multiple interactions ISO RGD:736208 6480464 Arsenic inhibits the reaction [CEBPB protein binds to PPARG protein] CTD PMID:23108036 arsenic atom multiple interactions ISO RGD:736208 6480464 Arsenic inhibits the reaction [CEBPB protein binds to PPARG protein] CTD PMID:23108036 arsenic atom decreases expression ISO RGD:736208 6480464 Arsenic results in decreased expression of CEBPB mRNA, Arsenic results in decreased expression of CEBPB protein CTD PMID:23108036 arsenite(3-) multiple interactions ISO RGD:736208 6480464 arsenite promotes the reaction [CEBPB protein binds to DDIT4 promoter] CTD PMID:16008523 arsenite(3-) multiple interactions EXP 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of CEBPB mRNA] CTD PMID:18929588 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of CEBPB mRNA CTD PMID:18929588 arsenite(3-) increases activity ISO RGD:736208 6480464 arsenite results in increased activity of CEBPB protein CTD PMID:16008523 arsenous acid decreases expression ISO RGD:736208 6480464 Arsenic Trioxide results in decreased expression of CEBPB mRNA CTD PMID:20471514 arsenous acid decreases methylation ISO RGD:736208 6480464 Arsenic Trioxide results in decreased methylation of CEBPB promoter CTD PMID:26046465 arsenous acid multiple interactions ISO RGD:736208 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CEBPB mRNA more ... CTD PMID:15894607 more ... arsenous acid increases expression ISO RGD:736208 6480464 Arsenic Trioxide results in increased expression of CEBPB mRNA, Arsenic Trioxide results in increased expression of CEBPB protein CTD PMID:19690170 more ... astemizole increases expression ISO RGD:2327 6480464 Astemizole results in increased expression of CEBPB mRNA CTD PMID:20221588 atrazine multiple interactions ISO RGD:2327 6480464 [Atrazine co-treated with Colforsin] results in increased expression of CEBPB protein, Atrazine promotes the reaction [FSHB protein results in increased expression of CEBPB protein] CTD PMID:25253736 atrazine increases expression ISO RGD:736208 6480464 Atrazine results in increased expression of CEBPB mRNA CTD PMID:22378314 Azaspiracid increases expression ISO RGD:736208 6480464 azaspiracid results in increased expression of CEBPB mRNA CTD PMID:28939011 azoxystrobin affects expression ISO RGD:736208 6480464 azoxystrobin affects the expression of CEBPB mRNA CTD PMID:33512557 baicalein decreases expression EXP 6480464 baicalein results in decreased expression of CEBPB mRNA CTD PMID:24560969 beauvericin multiple interactions ISO RGD:736208 6480464 [beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA CTD PMID:31100301 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CEBPB mRNA CTD PMID:22228805 , PMID:27195522 benzo[a]pyrene increases methylation ISO RGD:736208 6480464 Benzo(a)pyrene results in increased methylation of CEBPB promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:736208 6480464 Benzo(a)pyrene metabolite results in decreased expression of CEBPB mRNA, Benzo(a)pyrene results in decreased expression of CEBPB mRNA CTD PMID:24356939 , PMID:32234424 benzo[a]pyrene increases expression ISO RGD:736208 6480464 Benzo(a)pyrene results in increased expression of CEBPB protein CTD PMID:32717239 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:736208 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 berberine affects phosphorylation EXP 6480464 Berberine affects the phosphorylation of CEBPB protein CTD PMID:28038998 berberine increases expression ISO RGD:736208 6480464 Berberine results in increased expression of CEBPB mRNA CTD PMID:28038998 berberine affects phosphorylation ISO RGD:736208 6480464 Berberine affects the phosphorylation of CEBPB protein CTD PMID:28038998 berberine multiple interactions ISO RGD:736208 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Berberine results in increased phosphorylation of CEBPB protein], CEBPB protein promotes the reaction [Berberine results in increased expression of CD36 mRNA] CTD PMID:28038998 betulinic acid decreases expression ISO RGD:736208 6480464 Betulinic Acid results in decreased expression of CEBPB protein modified form CTD PMID:30482226 betulinic acid multiple interactions ISO RGD:736208 6480464 Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form], Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of CEBPB protein alternative form] CTD PMID:30482226 betulinic acid multiple interactions EXP 6480464 Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form], Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of CEBPB protein alternative form] CTD PMID:30482226 bifenthrin multiple interactions ISO RGD:2327 6480464 bifenthrin inhibits the reaction [CGA protein results in increased expression of CEBPB mRNA] CTD PMID:21251947 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736208 6480464 Diethylhexyl Phthalate results in increased expression of CEBPB mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CEBPB mRNA CTD PMID:18359623 bisphenol A multiple interactions ISO RGD:736208 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA CTD PMID:33836827 bisphenol A decreases expression ISO RGD:736208 6480464 bisphenol A results in decreased expression of CEBPB mRNA CTD PMID:32387340 bisphenol A affects expression ISO RGD:736208 6480464 bisphenol A affects the expression of CEBPB mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:2327 6480464 bisphenol A results in increased expression of CEBPB mRNA CTD PMID:25181051 , PMID:34947998 bisphenol A multiple interactions ISO RGD:2327 6480464 bisphenol A inhibits the reaction [CEBPB protein binds to CPT1A promoter] CTD PMID:25748669 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CEBPB mRNA CTD PMID:26063408 , PMID:35598803 bisphenol A multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:25068083 , PMID:28433925 bisphenol A increases expression ISO RGD:736208 6480464 bisphenol A analog results in increased expression of CEBPB mRNA more ... CTD PMID:24418828 more ... Bisphenol B decreases expression ISO RGD:736208 6480464 bisphenol B results in decreased expression of CEBPB mRNA CTD PMID:32387340 bisphenol F multiple interactions ISO RGD:736208 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA CTD PMID:28628672 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of CEBPB mRNA CTD PMID:17177178 bleomycin A2 increases response to substance EXP 6480464 CEBPB protein results in increased susceptibility to Bleomycin CTD PMID:21998664 bleomycin A2 multiple interactions EXP 6480464 CEBPB protein affects the reaction [Bleomycin results in increased expression of ACTA2 mRNA] more ... CTD PMID:17177178 bleomycin A2 decreases response to substance EXP 6480464 CEBPB gene mutant form results in decreased susceptibility to Bleomycin CTD PMID:17177178 boric acid multiple interactions EXP 6480464 boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA] CTD PMID:28285642 bortezomib multiple interactions ISO RGD:736208 6480464 1 more ... CTD PMID:20471514 , PMID:30482226 bortezomib multiple interactions EXP 6480464 1 more ... CTD PMID:30482226 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of CEBPB protein alternative form CTD PMID:30482226 bortezomib increases expression ISO RGD:736208 6480464 Bortezomib results in increased expression of CEBPB protein alternative form CTD PMID:30482226 bortezomib increases expression ISO RGD:2327 6480464 Bortezomib results in increased expression of CEBPB protein CTD PMID:20830808 bortezomib decreases expression ISO RGD:736208 6480464 Bortezomib results in decreased expression of CEBPB mRNA CTD PMID:20471514 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of CEBPB protein CTD PMID:19282384 , PMID:19698295 bucladesine multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate promotes the reaction [Bucladesine results in increased expression of CEBPB protein] CTD PMID:19282384 butylated hydroxyanisole multiple interactions EXP 6480464 Butylated Hydroxyanisole inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] CTD PMID:21220312 C60 fullerene decreases expression ISO RGD:2327 6480464 fullerene C60 results in decreased expression of CEBPB mRNA CTD PMID:19167457 caffeine decreases expression ISO RGD:2327 6480464 Caffeine results in decreased expression of CEBPB mRNA CTD PMID:30528684 caffeine increases phosphorylation ISO RGD:736208 6480464 Caffeine results in increased phosphorylation of CEBPB protein CTD PMID:35688186 calcitriol decreases expression EXP 6480464 Calcitriol results in decreased expression of CEBPB mRNA, Calcitriol results in decreased expression of CEBPB protein CTD PMID:16467308 calcitriol increases expression ISO RGD:736208 6480464 Calcitriol results in increased expression of CEBPB mRNA, Calcitriol results in increased expression of CEBPB protein CTD PMID:14729647 more ... calcitriol multiple interactions ISO RGD:736208 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA] more ... CTD PMID:14729647 more ... calcitriol multiple interactions EXP 6480464 [Calcitriol results in increased expression of RUNX1T1 protein] which results in decreased activity of CEBPB protein CTD PMID:16467308 calcium atom affects expression ISO RGD:2327 6480464 Calcium affects the expression of CEBPB mRNA CTD PMID:15913539 calcium(0) affects expression ISO RGD:2327 6480464 Calcium affects the expression of CEBPB mRNA CTD PMID:15913539 cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of CEBPB mRNA CTD PMID:30742662 cannabidiol increases expression ISO RGD:736208 6480464 Cannabidiol results in increased expression of CEBPB mRNA CTD PMID:33244087 cannabidiol multiple interactions EXP 6480464 [lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of CEBPB mRNA CTD PMID:30742662 capsaicin multiple interactions EXP 6480464 [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA], [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] CTD PMID:21250977 capsaicin multiple interactions ISO RGD:736208 6480464 [CEBPB protein binds to GDF15 promoter] promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA] more ... CTD PMID:20110283 capsaicin increases activity EXP 6480464 Capsaicin results in increased activity of CEBPB protein CTD PMID:21250977 carbamazepine affects expression ISO RGD:736208 6480464 Carbamazepine affects the expression of CEBPB mRNA CTD PMID:24752500 , PMID:25979313 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbon nanotube affects expression EXP 6480464 Nanotubes more ... CTD PMID:23845593 , PMID:25554681 carboxy-PTIO multiple interactions EXP 6480464 1 more ... CTD PMID:30482226 carboxy-PTIO multiple interactions ISO RGD:736208 6480464 1 more ... CTD PMID:30482226 carmustine decreases expression ISO RGD:736208 6480464 Carmustine results in decreased expression of CEBPB mRNA CTD PMID:15980968 ceruletide multiple interactions ISO RGD:2327 6480464 [Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPB protein more ... CTD PMID:26873426 ceruletide increases expression ISO RGD:2327 6480464 Ceruletide results in increased expression of CEBPB mRNA CTD PMID:26873426 chloropicrin affects expression ISO RGD:736208 6480464 chloropicrin affects the expression of CEBPB mRNA CTD PMID:26352163 chloroprene increases expression ISO RGD:2327 6480464 Chloroprene results in increased expression of CEBPB mRNA CTD PMID:23125180 chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of CEBPB protein alternative form CTD PMID:30482226 chloroquine multiple interactions ISO RGD:736208 6480464 1 more ... CTD PMID:30482226 chloroquine increases expression ISO RGD:736208 6480464 Chloroquine results in increased expression of CEBPB protein alternative form CTD PMID:30482226 chloroquine multiple interactions EXP 6480464 1 more ... CTD PMID:30482226 choline multiple interactions EXP 6480464 [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... CTD PMID:20548288 more ... choline multiple interactions ISO RGD:736208 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] more ... CTD PMID:25712622 Chorionic gonadotropin multiple interactions EXP 6480464 [Gonadotropins, Equine co-treated with Chorionic Gonadotropin] results in increased expression of CEBPB mRNA CTD PMID:15831568 ciglitazone increases expression ISO RGD:2327 6480464 ciglitazone results in increased expression of CEBPB mRNA CTD PMID:22193206 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of CEBPB mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CEBPB mRNA CTD PMID:21151649 cisplatin affects expression ISO RGD:736208 6480464 Cisplatin affects the expression of CEBPB mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:736208 6480464 Cisplatin results in increased expression of CEBPB mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:736208 6480464 Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA] CTD PMID:21858171 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of CEBPB mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:736208 6480464 cobaltous chloride results in increased expression of CEBPB mRNA CTD PMID:22941251 cobalt dichloride decreases expression ISO RGD:736208 6480464 cobaltous chloride results in decreased expression of CEBPB protein CTD PMID:29673971 colforsin daropate hydrochloride multiple interactions ISO RGD:2327 6480464 [Atrazine co-treated with Colforsin] results in increased expression of CEBPB protein CTD PMID:25253736 colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of CEBPB mRNA CTD PMID:14684744 copper atom multiple interactions ISO RGD:736208 6480464 [NSC 689534 binds to Copper] which results in increased expression of CEBPB mRNA CTD PMID:20971185 copper atom decreases expression ISO RGD:2327 6480464 Copper results in decreased expression of CEBPB mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:736208 6480464 [NSC 689534 binds to Copper] which results in increased expression of CEBPB mRNA CTD PMID:20971185 copper(0) decreases expression ISO RGD:2327 6480464 Copper results in decreased expression of CEBPB mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:736208 6480464 Copper Sulfate results in increased expression of CEBPB mRNA CTD PMID:19549813 corticosterone increases expression ISO RGD:2327 6480464 Corticosterone results in increased expression of CEBPB mRNA CTD PMID:15755911 corticosterone multiple interactions ISO RGD:2327 6480464 CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA] more ... CTD PMID:18650268 cortisol affects expression ISO RGD:736208 6480464 Hydrocortisone affects the expression of CEBPB mRNA CTD PMID:30528684 cortisol multiple interactions ISO RGD:736208 6480464 Mifepristone affects the reaction [Hydrocortisone affects the expression of CEBPB mRNA] CTD PMID:30528684 crocidolite asbestos multiple interactions ISO RGD:736208 6480464 Asbestos more ... CTD PMID:8969274 , PMID:9378980 Cuprizon decreases expression ISO RGD:2327 6480464 Cuprizone results in decreased expression of CEBPB mRNA CTD PMID:26577399 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA] CTD PMID:18200517 cyclophosphamide decreases expression ISO RGD:736208 6480464 Cyclophosphamide metabolite results in decreased expression of CEBPB mRNA CTD PMID:24356939 cyclosporin A increases expression ISO RGD:736208 6480464 Cyclosporine results in increased expression of CEBPB mRNA CTD PMID:20106945 more ... D-glucose multiple interactions ISO RGD:736208 6480464 CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of CEBPB protein CTD PMID:29266779 D-glucose multiple interactions EXP 6480464 CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein] more ... CTD PMID:28482072 , PMID:29266779 DDE decreases activity ISO RGD:736208 6480464 Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPB protein CTD PMID:27589886 deguelin increases expression ISO RGD:736208 6480464 deguelin results in increased expression of CEBPB mRNA CTD PMID:33512557 deoxycholic acid increases expression ISO RGD:736208 6480464 Deoxycholic Acid results in increased expression of CEBPB CTD PMID:18444174 deoxycholic acid multiple interactions ISO RGD:736208 6480464 NRAS affects the reaction [Deoxycholic Acid results in increased expression of CEBPB], Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of CEBPB] CTD PMID:18444174 deoxynivalenol multiple interactions EXP 6480464 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3, 4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of CEBPB protein] CTD PMID:15772366 deoxynivalenol increases activity EXP 6480464 deoxynivalenol results in increased activity of CEBPB protein CTD PMID:15772366 deoxynivalenol affects localization EXP 6480464 deoxynivalenol affects the localization of CEBPB protein CTD PMID:12604842 dexamethasone multiple interactions EXP 6480464 14-deoxy-11 more ... CTD PMID:16054899 more ... dexamethasone multiple interactions ISO RGD:736208 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA, [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA CTD PMID:28628672 , PMID:33836827 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CEBPB mRNA CTD PMID:21041162 , PMID:22733784 dexamethasone increases expression ISO RGD:2327 6480464 Dexamethasone results in increased expression of CEBPB mRNA, Dexamethasone results in increased expression of CEBPB protein CTD PMID:14568882 more ... dexamethasone multiple interactions ISO RGD:2327 6480464 2-amino-4-(3 more ... CTD PMID:15661831 more ... diallyl trisulfide multiple interactions EXP 6480464 [diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN more ... CTD PMID:22137902 diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of CEBPB mRNA, diallyl trisulfide results in decreased expression of CEBPB protein CTD PMID:22137902 diarsenic trioxide increases expression ISO RGD:736208 6480464 Arsenic Trioxide results in increased expression of CEBPB mRNA, Arsenic Trioxide results in increased expression of CEBPB protein CTD PMID:19690170 more ... diarsenic trioxide decreases methylation ISO RGD:736208 6480464 Arsenic Trioxide results in decreased methylation of CEBPB promoter CTD PMID:26046465 diarsenic trioxide decreases expression ISO RGD:736208 6480464 Arsenic Trioxide results in decreased expression of CEBPB mRNA CTD PMID:20471514 diarsenic trioxide multiple interactions ISO RGD:736208 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CEBPB mRNA more ... CTD PMID:15894607 more ... diazinon affects expression ISO RGD:2327 6480464 Diazinon affects the expression of CEBPB mRNA CTD PMID:22546817 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 dibenziodolium multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of CEBPB protein] CTD PMID:25199686 dibutyl phthalate multiple interactions ISO RGD:2327 6480464 Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP11A1 promoter] more ... CTD PMID:17884934 dibutyl phthalate decreases expression ISO RGD:2327 6480464 Dibutyl Phthalate results in decreased expression of CEBPB mRNA, Dibutyl Phthalate results in decreased expression of CEBPB protein CTD PMID:15728792 more ... dichloromethane increases expression EXP 6480464 Methylene Chloride results in increased expression of CEBPB mRNA CTD PMID:28392392 diclofenac increases expression ISO RGD:736208 6480464 Diclofenac results in increased expression of CEBPB mRNA CTD PMID:19022234 diclofenac affects expression ISO RGD:736208 6480464 Diclofenac affects the expression of CEBPB mRNA CTD PMID:24752500 diclofenac increases expression ISO RGD:2327 6480464 Diclofenac results in increased expression of CEBPB mRNA CTD PMID:19022234 dieldrin affects expression ISO RGD:2327 6480464 Dieldrin affects the expression of CEBPB mRNA CTD PMID:22546817 diethylstilbestrol increases expression ISO RGD:736208 6480464 Diethylstilbestrol results in increased expression of CEBPB mRNA CTD PMID:19371625 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CEBPB mRNA CTD PMID:15289156 , PMID:21041162 Diisodecyl phthalate increases expression EXP 6480464 diisodecyl phthalate results in increased expression of CEBPB mRNA CTD PMID:29410257 diisononyl phthalate increases expression EXP 6480464 diisononyl phthalate results in increased expression of CEBPB mRNA CTD PMID:29410257 dimethyl sulfoxide increases expression ISO RGD:2327 6480464 Dimethyl Sulfoxide results in increased expression of CEBPB mRNA CTD PMID:22193206 dimethylarsinous acid decreases expression ISO RGD:736208 6480464 dimethylarsinous acid results in decreased expression of CEBPB mRNA CTD PMID:16507463 dinophysistoxin 1 increases expression ISO RGD:736208 6480464 dinophysistoxin 1 results in increased expression of CEBPB mRNA CTD PMID:28939011 dioxygen decreases expression ISO RGD:736208 6480464 Oxygen deficiency results in decreased expression of CEBPB mRNA CTD PMID:26516004 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPB mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 dorsomorphin multiple interactions EXP 6480464 dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPB protein]] CTD PMID:30446312 doxorubicin increases response to substance ISO RGD:736208 6480464 CEBPB results in increased susceptibility to Doxorubicin CTD PMID:9359698 doxorubicin multiple interactions ISO RGD:736208 6480464 [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of and affects the localization of CALR protein] more ... CTD PMID:30482226 doxorubicin multiple interactions EXP 6480464 Doxorubicin promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form] more ... CTD PMID:30482226 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CEBPB mRNA, Doxorubicin results in increased expression of CEBPB protein alternative form CTD PMID:25896364 , PMID:30482226 doxorubicin increases expression ISO RGD:736208 6480464 Doxorubicin results in increased expression of CEBPB mRNA, Doxorubicin results in increased expression of CEBPB protein alternative form CTD PMID:16001973 , PMID:30482226 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CEBPB protein CTD PMID:25199686 endosulfan multiple interactions EXP 6480464 diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of CEBPB protein] CTD PMID:25199686 endrin increases expression EXP 6480464 Endrin results in increased expression of CEBPB mRNA CTD PMID:34801515 enniatin multiple interactions ISO RGD:736208 6480464 [beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA CTD PMID:31100301 entinostat multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:736208 6480464 entinostat results in increased expression of CEBPB mRNA CTD PMID:26272509 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CEBPB mRNA CTD PMID:19167417 ethanol affects expression ISO RGD:2327 6480464 Ethanol affects the expression of CEBPB mRNA CTD PMID:26188107 ethyl methanesulfonate increases expression ISO RGD:736208 6480464 Ethyl Methanesulfonate results in increased expression of CEBPB mRNA CTD PMID:23649840 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of CEBPB mRNA CTD PMID:27029645 fenpyroximate increases expression ISO RGD:736208 6480464 fenpyroximate results in increased expression of CEBPB mRNA CTD PMID:33512557 flavone multiple interactions ISO RGD:2327 6480464 flavone results in increased localization of and results in increased activity of CEBPB protein CTD PMID:12663507 flavonoids increases expression ISO RGD:2327 6480464 Flavonoids results in increased expression of CEBPB mRNA CTD PMID:18035473 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPB mRNA CTD PMID:28329830 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20548288 more ... folic acid multiple interactions ISO RGD:736208 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEBPB mRNA CTD PMID:24657277 folpet increases expression EXP 6480464 folpet results in increased expression of CEBPB mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:736208 6480464 Formaldehyde results in increased expression of CEBPB mRNA CTD PMID:23649840 gallic acid decreases expression EXP 6480464 Gallic Acid results in decreased expression of CEBPB protein CTD PMID:24036142 gallocatechin decreases expression ISO RGD:2327 6480464 gallocatechol results in decreased expression of CEBPB mRNA CTD PMID:21877759 gamma-hexachlorocyclohexane increases expression ISO RGD:736208 6480464 Hexachlorocyclohexane results in increased expression of CEBPB mRNA CTD PMID:24356939 geldanamycin multiple interactions ISO RGD:2327 6480464 geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]] CTD PMID:11133817 gemcitabine increases expression ISO RGD:736208 6480464 Gemcitabine results in increased expression of CEBPB mRNA CTD PMID:17039268 gemfibrozil multiple interactions ISO RGD:736208 6480464 Gemfibrozil inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased activity of CEBPB protein] CTD PMID:12244038 genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Lipopolysaccharides results in increased activity of CEBPB protein] CTD PMID:15832817 genistein increases expression ISO RGD:2327 6480464 Genistein results in increased expression of CEBPB mRNA CTD PMID:24361872 genistein decreases expression EXP 6480464 Genistein results in decreased expression of CEBPB mRNA CTD PMID:18359623 , PMID:21048042 genistein increases expression EXP 6480464 Genistein results in increased expression of CEBPB mRNA CTD PMID:15289156 genistein increases expression ISO RGD:736208 6480464 Genistein results in increased expression of CEBPB mRNA CTD PMID:19371625 genistein 7-O-beta-D-glucoside multiple interactions EXP 6480464 genistin inhibits the reaction [Lipopolysaccharides results in increased activity of CEBPB protein] CTD PMID:15832817 geraniol increases expression ISO RGD:736208 6480464 geraniol results in increased expression of CEBPB mRNA CTD PMID:27683099 glucose multiple interactions EXP 6480464 CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein] more ... CTD PMID:28482072 , PMID:29266779 glucose decreases expression EXP 6480464 Glucose results in decreased expression of CEBPB protein CTD PMID:29266779 glucose multiple interactions ISO RGD:736208 6480464 CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... CTD PMID:24376792 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] CTD PMID:21220312 glycidol increases expression ISO RGD:2327 6480464 glycidol results in increased expression of CEBPB mRNA CTD PMID:24915197 glycyrrhizinic acid multiple interactions EXP 6480464 Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPB mRNA] CTD PMID:34302803 GW 4064 multiple interactions EXP 6480464 GW 4064 promotes the reaction [NR1H4 protein binds to CEBPB gene] CTD PMID:20091679 herbimycin multiple interactions ISO RGD:2327 6480464 herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] CTD PMID:11133817 hexadecanoic acid multiple interactions ISO RGD:2327 6480464 [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPB mRNA more ... CTD PMID:26873426 Honokiol decreases expression ISO RGD:736208 6480464 honokiol results in decreased expression of CEBPB protein CTD PMID:34973135 Honokiol multiple interactions ISO RGD:736208 6480464 4-phenylbutyric acid inhibits the reaction [honokiol results in decreased activity of CEBPB protein] more ... CTD PMID:34973135 hydrogen peroxide affects expression ISO RGD:736208 6480464 Hydrogen Peroxide affects the expression of CEBPB mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:736208 6480464 Hydrogen Peroxide promotes the reaction [CEBPB protein binds to IL6 promoter], tetramethylthiourea inhibits the reaction [Hydrogen Peroxide promotes the reaction [CEBPB protein binds to IL6 promoter]] CTD PMID:9378980 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of CEBPB mRNA CTD PMID:21220312 hydrogen peroxide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Hydrogen Peroxide results in increased expression of CEBPB mRNA], U 0126 inhibits the reaction [Hydrogen Peroxide results in increased expression of CEBPB mRNA] CTD PMID:21220312 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:736208 6480464 indeno(1 more ... CTD PMID:32251684 indirubin multiple interactions EXP 6480464 [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPB protein], [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPB protein] CTD PMID:18344322 indometacin multiple interactions ISO RGD:736208 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA CTD PMID:28628672 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB mRNA more ... CTD PMID:33412187 Iodine aqueous multiple interactions ISO RGD:736208 6480464 Lugol's solution inhibits the reaction [potassium perchlorate results in decreased expression of CEBPB protein] CTD PMID:29673971 iron(2+) sulfate (anhydrous) increases expression ISO RGD:736208 6480464 ferrous sulfate results in increased expression of CEBPB mRNA CTD PMID:19428942 isoniazide decreases expression EXP 6480464 Isoniazid results in decreased expression of CEBPB protein CTD PMID:24128855 ketamine increases expression ISO RGD:2327 6480464 Ketamine results in increased expression of CEBPB mRNA CTD PMID:20080153 L-ascorbic acid increases expression ISO RGD:2327 6480464 Ascorbic Acid results in increased expression of CEBPB mRNA CTD PMID:15372504 L-methionine multiple interactions EXP 6480464 [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... CTD PMID:20548288 , PMID:25712622 L-methionine multiple interactions ISO RGD:736208 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] more ... CTD PMID:25712622 L-serine decreases expression ISO RGD:736208 6480464 Serine results in decreased expression of CEBPB mRNA CTD PMID:29098664 lactacystin increases expression ISO RGD:736208 6480464 lactacystin results in increased expression of CEBPB protein CTD PMID:11779194 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of CEBPB mRNA CTD PMID:21829687 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CEBPB mRNA CTD PMID:25270620 lead(0) affects expression ISO RGD:736208 6480464 Lead affects the expression of CEBPB mRNA CTD PMID:22313790 lead(0) increases expression EXP 6480464 Lead results in increased expression of CEBPB CTD PMID:23086611 lead(2+) affects expression ISO RGD:736208 6480464 Lead affects the expression of CEBPB mRNA CTD PMID:22313790 lead(2+) increases expression EXP 6480464 Lead results in increased expression of CEBPB CTD PMID:23086611 leflunomide increases expression ISO RGD:2327 6480464 leflunomide results in increased expression of CEBPB mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:736208 6480464 leflunomide results in increased expression of CEBPB mRNA CTD PMID:28988120 levofloxacin increases expression ISO RGD:2327 6480464 Levofloxacin results in increased expression of CEBPB mRNA CTD PMID:24136188 linalool increases expression ISO RGD:2327 6480464 linalool results in increased expression of CEBPB mRNA CTD PMID:20536181 lipopolysaccharide increases expression ISO RGD:736208 6480464 Lipopolysaccharides results in increased expression of CEBPB mRNA CTD PMID:21911040 lipopolysaccharide increases expression ISO RGD:2327 6480464 Lipopolysaccharides results in increased expression of CEBPB mRNA, Lipopolysaccharides results in increased expression of CEBPB protein CTD PMID:11779202 more ... lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CEBPB mRNA, Lipopolysaccharides results in increased expression of CEBPB protein CTD PMID:17316017 , PMID:34952004 lipopolysaccharide increases activity EXP 6480464 Lipopolysaccharides results in increased activity of CEBPB protein CTD PMID:14670622 , PMID:15832817 lipopolysaccharide multiple interactions EXP 6480464 3 more ... CTD PMID:15832817 more ... lipopolysaccharide multiple interactions ISO RGD:736208 6480464 trichostatin A inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPB mRNA] CTD PMID:21911040 LY294002 multiple interactions ISO RGD:736208 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] CTD PMID:25712622 MeIQx increases phosphorylation ISO RGD:736208 6480464 2-amino-3 more ... CTD PMID:23208499 MeIQx affects response to substance ISO RGD:736208 6480464 CEBPB protein affects the susceptibility to 2-amino-3 more ... CTD PMID:23208499 melatonin multiple interactions ISO RGD:736208 6480464 CEBPB protein inhibits the reaction [Melatonin results in decreased activity of HDAC3 protein] CTD PMID:34973135 mercury dibromide increases expression ISO RGD:736208 6480464 mercuric bromide results in increased expression of CEBPB mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 mercury dichloride multiple interactions EXP 6480464 Mercuric Chloride results in increased expression of and results in increased activity of CEBPB protein CTD PMID:11267658 mercury dichloride increases stability EXP 6480464 Mercuric Chloride results in increased stability of CEBPB mRNA CTD PMID:11267658 methamphetamine increases expression ISO RGD:2327 6480464 Methamphetamine results in increased expression of CEBPB mRNA, Methamphetamine results in increased expression of CEBPB protein CTD PMID:19564919 , PMID:31059759 methamphetamine multiple interactions ISO RGD:736208 6480464 CEBPB protein affects the reaction [Methamphetamine results in decreased expression of PRKN protein], CEBPB protein affects the reaction [Methamphetamine results in increased expression of TRIB3 protein] CTD PMID:31059759 methamphetamine multiple interactions ISO RGD:2327 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of CEBPB mRNA more ... CTD PMID:19564919 , PMID:31059759 methotrexate increases expression ISO RGD:736208 6480464 Methotrexate results in increased expression of CEBPB mRNA CTD PMID:24657277 methotrexate decreases expression ISO RGD:736208 6480464 Methotrexate results in decreased expression of CEBPB mRNA CTD PMID:24449571 methotrexate multiple interactions ISO RGD:736208 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEBPB mRNA CTD PMID:24657277 methyl methanesulfonate increases expression ISO RGD:736208 6480464 Methyl Methanesulfonate results in increased expression of CEBPB mRNA CTD PMID:23649840 Methylazoxymethanol acetate decreases expression ISO RGD:2327 6480464 Methylazoxymethanol Acetate results in decreased expression of CEBPB mRNA CTD PMID:28349193 methylmercury chloride increases expression ISO RGD:736208 6480464 methylmercuric chloride results in increased expression of CEBPB mRNA CTD PMID:23179753 more ... methylmercury chloride decreases expression ISO RGD:736208 6480464 methylmercuric chloride results in decreased expression of CEBPB mRNA CTD PMID:34089799 methylmercury chloride multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 mifepristone multiple interactions ISO RGD:2327 6480464 Mifepristone promotes the reaction [CEBPB protein binds to NR3C1 protein] CTD PMID:18650268 mifepristone multiple interactions ISO RGD:736208 6480464 Mifepristone affects the reaction [Hydrocortisone affects the expression of CEBPB mRNA] CTD PMID:30528684 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CEBPB mRNA CTD PMID:25543134 Muraglitazar increases expression ISO RGD:2327 6480464 muraglitazar results in increased expression of CEBPB mRNA CTD PMID:21515302 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Hydrogen Peroxide results in increased expression of CEBPB mRNA] more ... CTD PMID:14684744 , PMID:21220312 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] CTD PMID:21220312 N-acetylsphingosine decreases localization ISO RGD:2327 6480464 N-acetylsphingosine results in decreased localization of CEBPB protein CTD PMID:15319326 N-acetylsphingosine multiple interactions ISO RGD:2327 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of CEBPB protein], N-acetylsphingosine inhibits the reaction [oltipraz results in increased localization of CEBPB protein] CTD PMID:15319326 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:736208 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPB protein, Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPB protein] CTD PMID:11779194 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:2327 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of CEBPB protein] CTD PMID:15319326 N-methyl-4-phenylpyridinium increases expression ISO RGD:736208 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CEBPB mRNA CTD PMID:24810058 naphthalenes increases expression ISO RGD:2327 6480464 Naphthalenes results in increased expression of CEBPB protein CTD PMID:17337753 nickel atom multiple interactions ISO RGD:736208 6480464 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide inhibits the reaction [[Nickel co-treated with lipopolysaccharide more ... CTD PMID:35623502 nickel dichloride increases expression ISO RGD:736208 6480464 nickel chloride results in increased expression of CEBPB mRNA CTD PMID:17312168 nickel dichloride affects expression ISO RGD:2327 6480464 nickel chloride affects the expression of CEBPB mRNA CTD PMID:22546817 nicotine increases expression ISO RGD:736208 6480464 Nicotine results in increased expression of CEBPB mRNA CTD PMID:18805435 nicotine multiple interactions ISO RGD:2327 6480464 [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA CTD PMID:29617909 nicotinic acid decreases expression EXP 6480464 Niacin results in decreased expression of CEBPB mRNA, Niacin results in decreased expression of CEBPB protein CTD PMID:21236357 nicotinic acid multiple interactions EXP 6480464 [Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA, Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter] CTD PMID:21236357 nitroprusside increases expression ISO RGD:736208 6480464 Nitroprusside results in increased expression of CEBPB protein alternative form CTD PMID:30482226 nitroprusside increases expression EXP 6480464 Nitroprusside results in increased expression of CEBPB protein alternative form CTD PMID:30482226 nitroprusside multiple interactions ISO RGD:736208 6480464 1 more ... CTD PMID:30482226 nitroprusside multiple interactions EXP 6480464 1 more ... CTD PMID:30482226 ochratoxin A decreases expression ISO RGD:736208 6480464 ochratoxin A metabolite results in decreased expression of CEBPB mRNA, ochratoxin A results in decreased expression of CEBPB mRNA CTD PMID:19287073 , PMID:24356939 ochratoxin A decreases expression ISO RGD:2327 6480464 ochratoxin A results in decreased expression of CEBPB mRNA CTD PMID:23358140 okadaic acid increases expression ISO RGD:736208 6480464 Okadaic Acid results in increased expression of CEBPB mRNA CTD PMID:28939011 oltipraz multiple interactions ISO RGD:2327 6480464 [Dexamethasone co-treated with oltipraz] results in increased activity of CEBPB protein more ... CTD PMID:12509401 more ... oxaliplatin increases expression ISO RGD:2327 6480464 oxaliplatin results in increased expression of CEBPB mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:2327 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CEBPB mRNA CTD PMID:25729387 oxidopamine increases expression ISO RGD:2327 6480464 Oxidopamine results in increased expression of CEBPB mRNA CTD PMID:12486162 ozone increases activity ISO RGD:736208 6480464 Ozone results in increased activity of CEBPB protein CTD PMID:16819095 , PMID:9124608 ozone increases expression EXP 6480464 Ozone results in increased expression of CEBPB mRNA CTD PMID:26342085 ozone multiple interactions ISO RGD:736208 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of CEBPB mRNA CTD PMID:31476115 ozone increases expression ISO RGD:736208 6480464 Ozone results in increased expression of CEBPB mRNA CTD PMID:31476115 p-chloromercuribenzoic acid increases expression ISO RGD:736208 6480464 p-Chloromercuribenzoic Acid results in increased expression of CEBPB mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:736208 6480464 panobinostat results in increased expression of CEBPB mRNA CTD PMID:26272509 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CEBPB mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of CEBPB mRNA CTD PMID:12595580 , PMID:21463325 paraquat increases expression ISO RGD:736208 6480464 Paraquat results in increased expression of CEBPB mRNA CTD PMID:23613995 pentane decreases expression ISO RGD:736208 6480464 pentane results in decreased expression of CEBPB mRNA CTD PMID:33064461 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CEBPB mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CEBPB mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:2327 6480464 Phenobarbital results in increased expression of CEBPB mRNA CTD PMID:19162173 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CEBPB mRNA CTD PMID:19270015 phenylmercury acetate increases expression ISO RGD:736208 6480464 Phenylmercuric Acetate results in increased expression of CEBPB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 PhIP increases phosphorylation ISO RGD:736208 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased phosphorylation of CEBPB protein CTD PMID:23208499 PhIP affects response to substance ISO RGD:736208 6480464 CEBPB protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine CTD PMID:23208499 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate promotes the reaction [Bucladesine results in increased expression of CEBPB protein] CTD PMID:19282384 phorbol 13-acetate 12-myristate decreases expression ISO RGD:736208 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CEBPB mRNA CTD PMID:33268675 phorone affects expression ISO RGD:2327 6480464 phorone affects the expression of CEBPB mRNA CTD PMID:18198479 picene decreases expression ISO RGD:736208 6480464 picene results in decreased expression of CEBPB mRNA CTD PMID:32251684 pirinixic acid increases expression ISO RGD:2327 6480464 pirinixic acid results in increased expression of CEBPB mRNA CTD PMID:19162173 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CEBPB mRNA CTD PMID:18301758 , PMID:18445702 piroxicam multiple interactions ISO RGD:736208 6480464 Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:736208 6480464 Piroxicam results in decreased expression of CEBPB mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:2327 6480464 Pregnenolone Carbonitrile results in increased expression of CEBPB mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of CEBPB mRNA CTD PMID:28903501 progesterone increases response to substance EXP 6480464 CEBPB protein results in increased susceptibility to Progesterone CTD PMID:23097472 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of CEBPB mRNA CTD PMID:21549006 progesterone increases expression ISO RGD:2327 6480464 Progesterone results in increased expression of CEBPB mRNA CTD PMID:20726854 prostaglandin J2 multiple interactions ISO RGD:2327 6480464 [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] results in increased activity of CEBPB protein CTD PMID:15150131 pyrazinecarboxamide increases expression ISO RGD:2327 6480464 Pyrazinamide results in increased expression of CEBPB mRNA CTD PMID:22431067 pyrimidifen increases expression ISO RGD:736208 6480464 pyrimidifen results in increased expression of CEBPB mRNA CTD PMID:33512557 pyrrolidine dithiocarbamate multiple interactions ISO RGD:736208 6480464 pyrrolidine dithiocarbamic acid promotes the reaction [CEBPB protein binds to LCMT2 promoter] CTD PMID:9359698 pyrrolidine dithiocarbamate increases response to substance ISO RGD:736208 6480464 CEBPB results in increased susceptibility to pyrrolidine dithiocarbamic acid CTD PMID:9359698 quercetin multiple interactions ISO RGD:2327 6480464 Quercetin inhibits the reaction [[Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPB protein] more ... CTD PMID:20501703 , PMID:26873426 quercetin increases expression ISO RGD:2327 6480464 Quercetin results in increased expression of CEBPB mRNA, Quercetin results in increased expression of CEBPB protein CTD PMID:20501703 quercetin multiple interactions ISO RGD:736208 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] more ... CTD PMID:11779194 more ... quercetin affects binding ISO RGD:736208 6480464 Quercetin binds to CEBPB protein CTD PMID:25875015 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] CTD PMID:25712622 raloxifene affects expression ISO RGD:736208 6480464 Raloxifene Hydrochloride affects the expression of CEBPB mRNA CTD PMID:14699072 raloxifene increases expression ISO RGD:736208 6480464 Raloxifene Hydrochloride results in increased expression of CEBPB mRNA CTD PMID:16497877 raloxifene multiple interactions ISO RGD:736208 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CEBPB mRNA CTD PMID:19059307 reactive oxygen species affects expression ISO RGD:736208 6480464 Reactive Oxygen Species affects the expression of CEBPB mRNA CTD PMID:25800948 resveratrol decreases expression EXP 6480464 resveratrol metabolite results in decreased expression of CEBPB mRNA more ... CTD PMID:22945685 more ... resveratrol multiple interactions EXP 6480464 resveratrol promotes the reaction [Lipopolysaccharides results in increased expression of CEBPB protein] CTD PMID:17316017 riboflavin increases expression ISO RGD:2327 6480464 Riboflavin deficiency results in increased expression of CEBPB mRNA, Riboflavin deficiency results in increased expression of CEBPB protein CTD PMID:16856317 rifampicin multiple interactions EXP 6480464 [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPB mRNA more ... CTD PMID:33412187 rolipram multiple interactions ISO RGD:2327 6480464 Rolipram promotes the reaction [FSHB protein results in increased expression of CEBPB protein] CTD PMID:25253736 rotenone increases expression ISO RGD:736208 6480464 Rotenone results in increased expression of CEBPB mRNA CTD PMID:29955902 rotenone increases expression ISO RGD:2327 6480464 Rotenone results in increased expression of CEBPB mRNA CTD PMID:32115830 rotenone multiple interactions ISO RGD:2327 6480464 troxerutin inhibits the reaction [Rotenone results in increased expression of CEBPB mRNA] CTD PMID:32115830 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CEBPB mRNA CTD PMID:23186747 rotenone multiple interactions EXP 6480464 CEBPB protein affects the reaction [Rotenone results in increased expression of GSTA1 mRNA], CEBPB protein affects the reaction [Rotenone results in increased expression of TRIB3 mRNA] CTD PMID:19304788 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:736208 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of CEBPB mRNA CTD PMID:33725128 SB 203580 multiple interactions ISO RGD:736208 6480464 SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein], SB 203580 inhibits the reaction [IFNG protein results in increased phosphorylation of CEBPB protein] CTD PMID:16355272 , PMID:24376792 SB 431542 multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:2327 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of CEBPB mRNA CTD PMID:19564919 sevoflurane affects expression ISO RGD:2327 6480464 sevoflurane affects the expression of CEBPB mRNA CTD PMID:15967596 sildenafil citrate multiple interactions EXP 6480464 8-(4-chlorophenylthio)guanosine 3', 5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of CEBPB protein] CTD PMID:20471953 sildenafil citrate increases expression EXP 6480464 Sildenafil Citrate results in increased expression of CEBPB mRNA, Sildenafil Citrate results in increased expression of CEBPB protein CTD PMID:20471953 silicon dioxide increases expression ISO RGD:736208 6480464 Silicon Dioxide analog results in increased expression of CEBPB mRNA, Silicon Dioxide results in increased expression of CEBPB mRNA CTD PMID:19428942 , PMID:25895662 silicon dioxide decreases expression ISO RGD:736208 6480464 Silicon Dioxide results in decreased expression of CEBPB mRNA CTD PMID:28425640 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CEBPB mRNA CTD PMID:19073995 silver atom increases expression EXP 6480464 Silver results in increased expression of CEBPB mRNA CTD PMID:27131904 silver atom increases expression ISO RGD:736208 6480464 Silver results in increased expression of CEBPB mRNA CTD PMID:26014281 silver(0) increases expression EXP 6480464 Silver results in increased expression of CEBPB mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:736208 6480464 Silver results in increased expression of CEBPB mRNA CTD PMID:26014281 sincalide multiple interactions ISO RGD:2327 6480464 [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPB mRNA more ... CTD PMID:26873426 sodium arsenite multiple interactions ISO RGD:736208 6480464 sodium arsenite results in increased expression of and affects the activity of CEBPB protein CTD PMID:14523996 sodium arsenite affects expression ISO RGD:736208 6480464 sodium arsenite affects the expression of CEBPB mRNA CTD PMID:34032870 Soman increases expression ISO RGD:2327 6480464 Soman results in increased expression of CEBPB mRNA CTD PMID:19281266 stavudine increases expression ISO RGD:2327 6480464 Stavudine results in increased expression of CEBPB mRNA CTD PMID:18299183 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of CEBPB protein CTD PMID:29266779 streptozocin multiple interactions EXP 6480464 CEBPB protein affects the reaction [Streptozocin results in increased expression of AGT protein] more ... CTD PMID:29266779 sulindac sulfide increases expression ISO RGD:736208 6480464 sulindac sulfide results in increased expression of CEBPB mRNA, sulindac sulfide results in increased expression of CEBPB protein CTD PMID:12734198 , PMID:16184548 sunitinib increases expression ISO RGD:736208 6480464 Sunitinib results in increased expression of CEBPB mRNA CTD PMID:31533062 tamibarotene increases expression ISO RGD:736208 6480464 tamibarotene results in increased expression of CEBPB mRNA CTD PMID:15498508 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of CEBPB mRNA CTD PMID:25123088 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of CEBPB mRNA CTD PMID:20937368 tamoxifen increases expression ISO RGD:736208 6480464 Tamoxifen results in increased expression of CEBPB mRNA CTD PMID:15604281 tamoxifen multiple interactions ISO RGD:736208 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of CEBPB mRNA CTD PMID:19059307 tamoxifen affects expression ISO RGD:736208 6480464 Tamoxifen affects the expression of CEBPB mRNA CTD PMID:14699072 tanespimycin decreases expression ISO RGD:736208 6480464 tanespimycin results in decreased expression of CEBPB protein CTD PMID:33609515 Tanshinone I multiple interactions EXP 6480464 [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPB protein], [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPB protein] CTD PMID:18344322 Tanshinone I increases expression EXP 6480464 tanshinone results in increased expression of CEBPB protein CTD PMID:18344322 tebufenpyrad increases expression ISO RGD:736208 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of CEBPB mRNA CTD PMID:33512557 telmisartan multiple interactions ISO RGD:2327 6480464 telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]] CTD PMID:19289654 tert-butyl hydroperoxide increases expression ISO RGD:736208 6480464 tert-Butylhydroperoxide results in increased expression of CEBPB mRNA CTD PMID:15336504 Tesaglitazar increases expression ISO RGD:2327 6480464 tesaglitazar results in increased expression of CEBPB mRNA CTD PMID:21270424 testosterone multiple interactions ISO RGD:2327 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of CEBPB mRNA] CTD PMID:20032058 tetrachloromethane multiple interactions EXP 6480464 CEBPB protein inhibits the reaction [Carbon Tetrachloride results in increased secretion of and results in increased activity of GPT protein] CTD PMID:15721291 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CEBPB mRNA CTD PMID:31919559 Tetramethylthiourea multiple interactions ISO RGD:736208 6480464 tetramethylthiourea inhibits the reaction [Asbestos more ... CTD PMID:9378980 thapsigargin increases expression ISO RGD:736208 6480464 Thapsigargin results in increased expression of CEBPB mRNA, Thapsigargin results in increased expression of CEBPB protein alternative form CTD PMID:22378314 more ... thapsigargin multiple interactions ISO RGD:736208 6480464 Thapsigargin promotes the reaction [CEBPB protein binds to NR1I2 promoter] CTD PMID:25616597 thifluzamide increases expression ISO RGD:736208 6480464 thifluzamide results in increased expression of CEBPB mRNA CTD PMID:33512557 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CEBPB mRNA CTD PMID:23557971 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CEBPB mRNA CTD PMID:29264374 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of CEBPB mRNA CTD PMID:17656681 topotecan multiple interactions ISO RGD:2327 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CEBPB mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:2327 6480464 Topotecan results in increased expression of CEBPB mRNA CTD PMID:25729387 torin 1 multiple interactions ISO RGD:736208 6480464 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... CTD PMID:30482226 torin 1 multiple interactions EXP 6480464 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... CTD PMID:30482226 tributylstannane increases expression ISO RGD:2327 6480464 tributyltin results in increased expression of CEBPB mRNA CTD PMID:21683754 , PMID:29908848 Tributyltin oxide increases expression ISO RGD:2327 6480464 bis(tri-n-butyltin)oxide results in increased expression of CEBPB mRNA CTD PMID:17553608 Tributyltin oxide increases expression EXP 6480464 bis(tri-n-butyltin)oxide results in increased expression of CEBPB mRNA CTD PMID:18958704 trichloroethene increases expression ISO RGD:2327 6480464 Trichloroethylene results in increased expression of CEBPB mRNA CTD PMID:19448997 trichloroethene decreases expression ISO RGD:2327 6480464 Trichloroethylene results in decreased expression of CEBPB mRNA CTD PMID:19448997 trichostatin A multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:21911040 , PMID:27188386 trichostatin A increases expression ISO RGD:736208 6480464 trichostatin A results in increased expression of CEBPB mRNA CTD PMID:24935251 , PMID:26272509 triclosan increases expression ISO RGD:736208 6480464 Triclosan results in increased expression of CEBPB mRNA CTD PMID:30510588 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of CEBPB mRNA CTD PMID:28163246 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CEBPB mRNA CTD PMID:12732648 troglitazone increases expression ISO RGD:2327 6480464 troglitazone results in increased expression of CEBPB mRNA CTD PMID:21515302 , PMID:21877759 troglitazone increases expression ISO RGD:736208 6480464 troglitazone results in increased expression of CEBPB mRNA CTD PMID:19140230 tunicamycin increases expression ISO RGD:736208 6480464 Tunicamycin results in increased expression of CEBPB mRNA CTD PMID:22378314 more ... tunicamycin multiple interactions EXP 6480464 CEBPB protein inhibits the reaction [Tunicamycin results in decreased expression of PPARGC1A protein] CTD PMID:28482072 undecane increases expression ISO RGD:2327 6480464 undecane results in increased expression of CEBPB protein CTD PMID:17337753 urethane increases expression ISO RGD:736208 6480464 Urethane results in increased expression of CEBPB mRNA CTD PMID:28818685 ursodeoxycholic acid multiple interactions ISO RGD:736208 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of CEBPB] CTD PMID:18444174 valproic acid increases methylation ISO RGD:736208 6480464 Valproic Acid results in increased methylation of CEBPB gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:736208 6480464 Valproic Acid results in decreased expression of CEBPB mRNA CTD PMID:29501571 valproic acid multiple interactions ISO RGD:736208 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736208 6480464 Valproic Acid results in increased expression of CEBPB mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO RGD:2327 6480464 vinclozolin affects the expression of CEBPB mRNA CTD PMID:19015723 vincristine increases expression ISO RGD:736208 6480464 Vincristine results in increased expression of CEBPB mRNA CTD PMID:16001973 vitamin D multiple interactions ISO RGD:736208 6480464 [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA CTD PMID:33836827 vitamin E increases response to substance ISO RGD:736208 6480464 CEBPB results in increased susceptibility to Vitamin E CTD PMID:9359698 zearalenone increases expression ISO RGD:736208 6480464 Zearalenone results in increased expression of CEBPB mRNA CTD PMID:25424538 zinc atom multiple interactions ISO RGD:2327 6480464 [Thymic Factor, Circulating co-treated with Zinc] results in increased activity of CEBPB protein CTD PMID:12639846 zinc atom increases expression ISO RGD:2327 6480464 Zinc results in increased expression of CEBPB mRNA CTD PMID:17074742 zinc sulfate increases expression ISO RGD:2327 6480464 Zinc Sulfate results in increased expression of CEBPB mRNA CTD PMID:17074742 zinc(0) multiple interactions ISO RGD:2327 6480464 [Thymic Factor, Circulating co-treated with Zinc] results in increased activity of CEBPB protein CTD PMID:12639846 zinc(0) increases expression ISO RGD:2327 6480464 Zinc results in increased expression of CEBPB mRNA CTD PMID:17074742 zoledronic acid increases expression ISO RGD:736208 6480464 zoledronic acid results in increased expression of CEBPB mRNA CTD PMID:24714768